REGULATION OF CD45 ENGAGEMENT BY THE B-CELL RECEPTOR CD22

被引:83
|
作者
SGROI, D
KORETZKY, GA
STAMENKOVIC, I
机构
[1] MASSACHUSETTS GEN HOSP EAST,DEPT PATHOL,BOSTON,MA 02129
[2] MASSACHUSETTS GEN HOSP EAST,CTR CANC,BOSTON,MA 02129
[3] MASSACHUSETTS GEN HOSP EAST,PATHOL RES LAB,BOSTON,MA 02129
[4] HARVARD UNIV,SCH MED,BOSTON,MA 02129
[5] UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242
[6] UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
关键词
D O I
10.1073/pnas.92.9.4026
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The B-cell receptor CD22 binds sialic acid linked alpha-2-6 to terminal galactose residues on N-linked oligosaccharides associated with several cell-surface glycoproteins. The first of these sialoglycoproteins to be identified was the receptor-linked phosphotyrosine phosphatase CD45, which is required for antigen/CD3-induced T-cell activation. In the present work we examine the effect of interaction between the extracellular domain of CD45 and CD22 on T-cell activation. Using soluble CD22-immunoglobulin fusion proteins acid T cells expressing wild-type and chimeric CD45 forms, we show that engagement of CD45 by soluble CD22 can modulate early T-cell signals in antigen receptor/CD3-mediated stimulation. We also show that addition of sialic acid by beta-galactoside alpha-2,6-sialyltransferase to the CD22 molecule abrogates interactions between CD22 and its ligands. Together, these observations provide direct evidence for a functional role of the interaction between the extracellular domain of CD45 and a natural ligand and suggest another regulatory mechanism for CD22-mediated ligand engagement.
引用
收藏
页码:4026 / 4030
页数:5
相关论文
共 50 条
  • [31] Targeting the CD22 receptor on human B-cell lymphomas with RNA damaging agents.
    Newton, DL
    Mikulski, SM
    Sausville, EA
    Rybak, SM
    CLINICAL CANCER RESEARCH, 2000, 6 : 4560S - 4560S
  • [32] REGULATION OF BASAL TYROSINE PHOSPHORYLATION AND FUNCTION OF THE B-CELL ANTIGEN RECEPTOR COMPLEX BY THE PROTEIN TYROSINE PHOSPHATASE, CD45
    LIN, J
    BROWN, VK
    JUSTEMENT, LB
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A262 - A262
  • [33] Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents
    Newton, DL
    Hansen, HJ
    Liu, HT
    Ruby, D
    Iordanov, MS
    Magun, BE
    Goldenberg, DM
    Rybak, SM
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 39 (1-2) : 79 - 86
  • [34] THE B-CELL ANTIGEN CD22 MEDIATES MONOCYTE AND ERYTHROCYTE ADHESION
    STAMENKOVIC, I
    SEED, B
    NATURE, 1990, 345 (6270) : 74 - 77
  • [35] HEMATOPOIETIC-CELL PHOSPHATASE IS RECRUITED TO CD22 FOLLOWING B-CELL ANTIGEN RECEPTOR LIGATION
    LANKESTER, AC
    VANSCHIJNDEL, GMW
    VANLIER, RAW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) : 20305 - 20308
  • [36] In vivo targeting of B-cell lymphoma with glycan ligands of CD22
    Chen, Weihsu C.
    Completo, Gladys C.
    Sigal, Darren S.
    Crocker, Paul R.
    Saven, Alan
    Paulson, James C.
    BLOOD, 2010, 115 (23) : 4778 - 4786
  • [37] The role of CD45 in the regulation of B cell subset functions in Atherosclerosis
    Ma, Shelby
    Moriarty, Alina K.
    Keeter, William Coles
    Waseem, Tayab
    Zyskin, Alexander
    Gauronskas, Philip
    Mussbacher, Marion
    Galkina, Elena
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [38] DEVELOPMENT OF HUMAN B-CELL LINES DEFICIENT IN CD19, CD20, OR CD22
    WILSON, GL
    RIVA, A
    KEHRL, JH
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A99 - A99
  • [39] STALing B cell responses with CD22
    Chappell, Craig P.
    Clark, Edward A.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07): : 2778 - 2780
  • [40] Regulation of Human CD27+IgM+B Cell Activation by Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L)
    Dijke, Esme
    Derkatz, Kim
    Pearcey, Jean
    Wong, Fred
    Motyka, Bruce
    West, Lori
    TRANSPLANTATION, 2017, 101 (05) : S5 - S5